[C:1]([O:5][C:6](=[O:18])[NH:7][CH:8]1[CH2:13][CH2:12][N:11]([CH2:14][CH:15](O)[CH3:16])[CH2:10][CH2:9]1)([CH3:4])([CH3:3])[CH3:2].CCN(S(F)(F)[F:25])CC>C(Cl)Cl>[C:1]([O:5][C:6](=[O:18])[NH:7][CH:8]1[CH2:13][CH2:12][N:11]([CH2:14][CH:15]([F:25])[CH3:16])[CH2:10][CH2:9]1)([CH3:4])([CH3:3])[CH3:2]To a cold solution of [1-(2-hydroxy-propyl)-piperidin-4-yl]-carbamic acid tert-butyl ester (0.70 g, 2.7 mmol) in DCM (30 mL) was added DAST (1.1 mL, 8.1 mmol) and the mixture was stirred at 25° C. for 20 h. The reaction mixture was washed with saturated sodium bicarbonate solution, water, brine, dried over Na2SO4 and concentrated under reduced pressure to afford [1-(2-fluoro-propyl)-piperidin-4-yl]-carbamic acid tert-butyl ester (0.5 g, 70%). LCMS (Method G; ESI): RT=0.53 min; m+1=261.3. This was used without further purification below.